Viropharma, Inc. (Nasdaq: VPHM) announced important data from an open-label, multicenter study to assess the safety, tolerability, and treatment effect ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE